Top Institutions in Ophthalmology and Gene Therapy
Institutions leading in this area typically have strong ophthalmology departments with dedicated retinal disease research programs, expertise in gene therapy development, and active clinical trials in AMD and GA. Their work often involves translational research bridging molecular mechanisms of complement activation and neurodegeneration with innovative therapeutic approaches.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is renowned for its pioneering research in retinal degenerative diseases and gene therapy, with extensive clinical trials targeting AMD and complement pathways.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with a strong focus on AMD clinical trials and gene therapy innovations.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a long-standing reputation in retinal research and gene therapy development, including studies on complement system modulation in AMD.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in gene therapy research and clinical trials for retinal diseases, with expertise in complement modulation and neuroprotection.
-
#5
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
Moorfields and UCL are internationally recognized for their cutting-edge research in retinal diseases and gene therapy, including complement system targeting in GA.